Zimmer Holdings Inc (ZMH): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Zimmer Holdings ( ZMH) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.4%. By the end of trading, Zimmer Holdings fell $0.86 (-1.0%) to $83.62 on average volume. Throughout the day, 1,189,490 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1,020,400 shares. The stock ranged in price between $83.02-$84.00 after having opened the day at $83.82 as compared to the previous trading day's close of $84.48. Other companies within the Health Services industry that declined today were: Pingtan Marine Enterprise ( PME), down 11.1%, Haemonetics Corporation ( HAE), down 7.7%, Dehaier Medical Systems ( DHRM), down 6.2% and Medical Action Industries ( MDCI), down 5.2%.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $14.0 billion and is part of the health care sector. Shares are up 26.7% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate Zimmer Holdings a buy, 1 analyst rates it a sell, and 15 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the positive front, Spherix ( SPEX), up 26.3%, IsoRay ( ISR), up 12.1%, InspireMD ( NSPR), up 11.2% and ImmunoCellular Therapeutics ( IMUC), up 10.0% , were all gainers within the health services industry with Community Health Systems ( CYH) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Zimmer Biomet's Prognosis Is Promising

Zimmer Biomet's Prognosis Is Promising

St. Jude Buying Thoratec Could Resusitate Medtech M&As

Analysts' Actions -- AT&T, Fitbit, Netflix and More

Barbarian At The Gate: Zimmer Holdings (ZMH)

Deal Delay Minor Obstacle for Zimmer

Deal Delay Minor Obstacle for Zimmer